Advanced bladder cancers respond to immunotherapy regardless of gene mutation status
Research News Release
EurekAlert! provides eligible reporters with free access to embargoed and breaking news releases.
Eligibility GuidelinesEurekAlert! offers eligible public information officers paid access to a reliable news release distribution service.
Eligibility GuidelinesEurekAlert! is a service of the American Association for the Advancement of Science.
UNC Lineberger researchers and colleagues report a study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy in a manner that is similar to patients without that mutation. This discovery runs counter to previous research that suggested FGFR3-mutated bladder cancers should not be treated with immunotherapy.
Having friends may not only be good for the health of your social life, but also for your actual health--if you're a hyena, that is. Strong social connections and greater maternal care early in life can influence molecular markers related to gene expression in DNA and future stress response, suggests a new University of Colorado Boulder study of spotted hyenas in the wild.
In a new PLOS Genetics study, researchers have uncovered evidence showing that cattle are losing important environmental adaptations, losses the researchers attribute to a lack of genetic information available to farmers. After examining genetic material stretching back to the 1960s, they identified specific DNA variations associated with adaptations that could one day be used to create DNA tests for cattle -- tests that could tell farmers whether their cattle are suited for one environment or another.
A new tool that enables thousands of tiny experiments to run simultaneously on a single polymer chip will let scientists study enzymes faster and more comprehensively than ever before.
After examining nearly the entire human genome for genetic changes that increase risk of aneurysm, researchers discovered a new change in the genetic code of a transcription factor.
International consortium, including then IGC, now current ITQB NOVA PI and GREEN-IT member Jörg Becker, offers novel insight into the reproductive evolution of land plants, in new study published in Nature Plants.
Scientists have completed the largest and most diverse genetic study of type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.
Advances in microscopy reveal how the human genome organises itself in three-dimensional space at much higher resolution than previously possible. A new study finds that transcription generates a force that moves across DNA strands like ripples through water. The discovery may have future implications for the understanding of genetic diseases such as Cornelia de Lange syndrome, developmental disorders linked to chromatin folding, and open new avenues of research in genome fragility and cancer development.
A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH's National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and blindness.
Geneticists from Trinity College Dublin have discovered how a specific genetic mutation (H3K27M) causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and - in lab studies working with model cell types - successfully reverse its effects to slow cancer cell growth with a targeted drug. Their landmark work - just published in leading international journal, Nature Genetics - translates crucial new understanding of the genetics of DMG progression into a highly promising, targeted therapeutic approach and offers significant hope of improved treatments in the future.